As a result, GYPC siRNA, but not the control siRNA, almost completely blocked the ORM2-induced increase in IL6 and CXCL8 mRNA expression in RA-FLSs (Fig. 4d, e). The gene discussed is ORM2; the disease is rheumatoid arthritis.